🔗 Share this article

A shadow economy for unlicensed slimming drugs is being driven by TikTok fitness influencers and vendors on messaging platforms, according to recent findings.

Experimental Drug Gaining Traction Via Social Media

The experimental drug, which remains in clinical trials, is being promoted by online personalities for its supposed fat-burning properties. Followers are urged to contact these accounts privately for source information, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Additionally, a robust market exists on Telegram, where groups with numerous of participants share “before and after” images, administration instructions and assertions of next-day British shipping. Vendors market the drug there before redirecting buyers to other platforms for transactions.

Understanding The Experimental Drug

This medication is an experimental injectable developed by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, glucose-dependent insulinotropic polypeptide and glucagon. Early trials suggest it could help patients lose up to 25% of their body weight. Nicknamed the “triple G”, the drug is being hailed online as the next Ozempic.

Healthcare Experts Express Worries

Nevertheless, physicians and pharmacists have warned that the sale of what remains an unapproved drug in the United Kingdom is worrisome and could lead to users administering substances of unknown origin.

Several experts stated the demand for the experimental drug could be linked to the increasing price of licensed weight loss products such as Mounjaro.

Regulatory Position and Implementation

Marketing the unapproved drug on social media or messaging apps is prohibited in the United Kingdom, as it is an unapproved medication that cannot be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.

Several content creators attempt to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted substance, but advertising and supply can still breach medicines, advertising, and customer laws, risking fines, legal action or imprisonment.

Service Reaction and Material Elimination

According to TikTok, the service has removed problematic material and banned related keywords and query recommendations. The organization stated it was dedicated to keeping the platform safe and investing in enhancing compliance measures.

Online Marketplace Operations

Investigations also discovered groups with up to nine thousand participants selling the experimental drug using Telegram's integrated search feature, which functions like a online catalog. Typing “retatrutide” immediately brings up groups with numerous of users, populated with photos of slimming results, positive reviews and step-by-step guides for preparing or administering at home.

Within moments of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller said: “You can’t be sure.” Another shared a image of a supposed laboratory certificate. None asked about weight, medical conditions or past usage.

Item Details and Pricing

Inside these communities, messages show black plastic packages with Royal Mail labels, stating to include new batches. One message read: “It took eight of us to load them this morning.”

Customers can choose between powder vials, prepared at home with purified liquid, or ready-to-use pens typically sold at £160 for 20mg. When questioned how much time a pen should last, vendors give contradictory responses varying between a several days to “depends on your body”.

Platform Moderation and Security Measures

A representative for the messaging service stated it actively monitored harmful content on its platform including material that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.

Healthcare Expert Warnings

“Individuals are injecting substances they can’t verify. Even if the research behind retatrutide is valid, these digital versions may not contain what they advertise,” stated a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in interest to recent cost increases for authorized slimming drugs such as Mounjaro. “With prices increasing, patients are turning to online platforms. But counterfeit treatments are extremely risky. You can’t be certain what’s contained or whether the environment they were made in was sterile,” she explained.

Her team has previously seen patients harmed by self-injection from unverified suppliers. “We understand the disappointment, but buying from messaging apps or WhatsApp is gambling with your health,” stated Wyllie. “These substances could be contaminated or improperly measured.”

Manufacturer Position

A representative from Eli Lilly said retatrutide was in third stage research studies and had not been reviewed or authorized by any government authority anywhere in the world. “Therefore at this time no one can sell [it] for personal consumption,” they explained, noting that any item “falsely representing itself as a Lilly experimental product not yet approved … may subject users to potentially significant medical dangers”.